- The Dispatch @ DiscussPharma
- Posts
- The Pharma Dispatch š - Issue #84
The Pharma Dispatch š - Issue #84
A film festival focused on rare diseases, the cancer drug pricing firestorm, smartphones now detect jaundice and other interesting reads from this week.
General
FDA approval of a āliving drugā heralds a new era in cancer care. Link
The cancer drug pricing firestorm. Link
Gileadās expanding portfolio of expensive drugs. Link
Pharma leads profitable second quarter for health care. Link
Peter Thiel funds āunethicalā offshore herpes vaccine trial. Link
A 'party drug' just crossed a major hurdle on the path to being legal medicine. Link
Why a Chinese internet giant is plowing tens of millions into American health tech start-ups. Link
The quest to modernize snakebite medicine. Link
Digital Health
This VR game may help neuroscientists test dementia. Link
Smartphones now detect jaundice. Link
Research
KYOCERA begins research in AI-based image recognition to tackle skin cancer. Link
Online game challenges players to design on/off switch for CRISPR. Link
Perspective and Opinions
Innovative drugs deserve innovative pricing. Link
Under pressure: A day in the grueling life of a pharma representative in India. Link
The problems with direct to consumer genetic testing companies. Link
Interesting
A film festival focused on rare diseases. Link
10 biotech firms on the forefront of anti-aging. Link
Startups of the Week
SynAgile focuses on developing and commercializing transformative therapeutics using its proprietary OraFuse oral dosing technology, with an initial focus on treating debilitating motor complications in patients with Parkinsonās disease.
Shuidi is a China-based crowdfunding platform within Tencent's WeChat mobile app that helps finance medical bills.
Likarda is a biotech research laboratory focused on advancing diabetes treatments for dogs and cat.
Access Vascular is developing the HydroPICC, a peripherally inserted central catheter that has been shown in lab testing to reduce the accumulation of platelets and in turn, the risk of thrombosis.